Speakers

Tim has recently joined LBC, bringing with him a range of experience from both the health and philanthropic sectors. Since returning from the UK in 2012, Tim has held leadership roles at health charities including Cure Kids, Cure Kids Fiji, and Well Foundation.

Throughout his career, Tim has worked closely with researchers and clinicians on funding solutions that help translate new ideas into community impact across various health challenges. These have included mental health, rheumatic heart disease, newborn and infant care, and cancer.

Tim is eager to build on LBC’s impact, both in the support provided for blood cancer patients and their families, and in transforming patient outcomes through research and advocacy.

Dr Danny Hsu is consultant laboratory and clinical haematologist based at Liverpool Hospital and Southern Highlands Private Hospital.  He is Director of Therapeutic Apheresis and Clinical Lead of Immune Haematology at Liverpool Hospital.

Dr Hsu's primary clinical and research interest is in the field of ITP, thrombotic microangiopathies (TTP and aHUS) and paroxysmal nocturnal haemoglobinuria.  He is a current sitting member of the THANZ Council, ISTH World Thrombosis Day Steering Committee, and the ISTH Philanthropy Advisory Board.

Dr Jad Othman is a clinical and laboratory haematologist working at Royal North Shore Hospital in Sydney. His interests are in AML and molecular genomics, especially the application of MRD to direct therapy and improve outcomes.

He completed a clinical research fellowship at Kings College London where he was involved with the NCRI AML working group and published a number of practice-informing studies.

He is an active contributor to the ALLG AML/MDS working party, including as a member of the MRD reference committee for the AMLM26 INTERCEPT study.